Skip to main content
. Author manuscript; available in PMC: 2013 Aug 29.
Published in final edited form as: Cancer Causes Control. 2011 Mar 24;22(6):859–868. doi: 10.1007/s10552-011-9756-1

Table 3.

Men cancer site-specific incidence, adjusted HRs, and 95% CIs, by tobacco use: Mumbai cohort study, Mumbai, Maharashtra, India, 1991–2003

Cancer sitea Never-user Smokeless Smoker Bidib Cigarette
All cancer sites n 273 476 518 295 223
HR (95% CI) 1.0 1.20 (1.03–1.41) 2.00 (1.72–2.32) 2.11 (1.77–2.53) 1.92 (1.60–2.29)
Lip, oral cavity
and pharynx
(C00–14)
n 44 107 136 89 47
HR (95% CI) 1.0 1.48 (1.03,2.13) 3.03 (2.14,4.29) 3.55 (2.40,5.24) 2.50 (1.65,3.78)
Tongue
(C01, 02)
n 14 19 32 18 14
HR (95% CI) 1.0 0.85 (0.42,1.74) 2.34 (1.23,4.45) 1.92 (0.91,4.05) 2.41 (1.14,5.08)
Gum
(C03)
n 3 11 12 10 2
HR (95% CI) 1.0 2.05 (0.55,7.64) 3.94 (1.09,14.26) 6.46 (1.64,25.40) 1.52 (0.25,9.18)
Mouth
(C04,5,6)
n 15 22 22 17 5
HR (95% CI) 1.0 0.78 (0.40,1.54) 1.27 (0.65,2.50) 1.79 (0.84,3.82) 0.67 (0.24,1.85)
Pyriform sinus
(C12)
n 8 24 25 16 9
HR (95% CI) 1.0 1.97 (0.85,4.58) 2.96 (1.31,6.68) 2.97 (1.20,7.36) 3.06 (1.16,8.05)
Digestive organs
(C15–26)
n 76 159 121 61 60
HR (95% CI) 1.0 1.43 (1.07,1.90) 1.70 (1.27,2.28) 1.55 (1.07,2.23) 1.83 (1.30,2.58)
Esophagus
(C15)
n 7 36 40 22 18
HR (95% CI) 1.0 3.65 (1.59,8.38) 5.75 (2.54,12.98) 5.46 (2.23,13.58) 5.72 (2.38,13.76)
Stomach
(C16)
n 16 31 20 9 11
HR (95% CI) 1.0 1.28 (0.67,2.43) 1.21 (0.62,2.37) 0.98 (0.41,2.33) 1.51 (0.69,3.29)
Colon
(C18)
n 12 20 14 8 6
HR (95% CI) 1.0 1.22 (0.57,2.61) 1.33 (0.60,2.94) 1.24 (0.47,3.30) 1.14 (0.42,3.07)
Rectum
(C20)
n 18 13 6 2 4
HR (95% CI) 1.0 0.48 (0.22,1.02) 0.40 (0.15,1.01) 0.24 (0.05,1.11) 0.57 (0.19,1.70)
Liver and intrahepatic
bile ducts
(C22)
n 9 31 16 9 7
HR (95% CI) 1.0 2.35 (1.08,5.10) 2.00 (0.87,4.61) 2.43 (0.88,6.72) 1.96 (0.72,5.31)
Pancreas
(C25)
n 5 15 17 7 10
HR (95% CI) 1.0 1.95 (0.68,5.54) 3.86 (1.40,10.66) 2.92 (0.85,10.02) 4.66 (1.58,13.71)
Respiratory and intrathoracic
organs
(C30–39)
n 27 64 114 76 38
HR (95% CI) 1.0 1.71 (1.08,2.73) 4.30 (2.80,6.60) 5.54 (3.46,8.87) 3.28 (1.99,5.39)
Larynx
(C32)
n 9 26 40 28 12
HR (95% CI) 1.0 1.86 (0.85,4.06) 4.33 (2.07,9.05) 6.10 (2.72,13.69) 2.87 (1.21,6.85)
Bronchus and lung
(C34)
n 17 34 65 41 24
HR (95% CI) 1.0 1.59 (0.87,2.90) 4.05 (2.35,7.00) 4.69 (2.56,8.59) 3.48 (1.86,6.52)
Male genital organ
(C60–63)
n 33 26 24 11 13
HR (95% CI) 1.0 0.71 (0.41,1.23) 0.96 (0.56,1.65) 0.77 (0.38,1.59) 1.16 (0.60,2.23)
Prostate
(C61)
n 30 20 20 9 11
HR (95% CI) 1.0 0.63 (0.35,1.15) 0.91 (0.51,1.63) 0.73 (0.33,1.61) 1.13 (0.56,2.27)
Urinary tract
(C64–68)
n 15 23 27 14 13
HR (95% CI) 1.0 1.17 (0.59,2.31) 1.99 (1.04,3.81) 1.79 (0.81,3.94) 2.05 (0.96,4.35)
Bladder
(C67)
n 10 15 20 9 11
HR (95% CI) 1.0 1.19 (0.52,2.76) 2.16 (0.98,4.73) 1.62 (0.61,4.25) 2.78 (1.16,6.64)
Ill-defined, secondary
and unspecified sites
(C76–80)
n 15 23 31 19 12
HR (95% CI) 1.0 1.13 (0.57,2.23) 2.10 (1.12,3.96) 2.72 (1.30,5.71) 1.83 (0.85,3.93)
Unspecified site
C80
n 11 17 29 17 12
HR (95% CI) 1.0 1.12 (0.51,2.48) 2.65 (1.30,5.41) 3.17 (1.39,7.25) 2.50 (1.09,5.70)
Lymphoid, haematopoietic
and related tissue
(C81–96)
n 40 44 37 14 23
HR (95% CI) 1.0 0.75 (0.48,1.18) 1.06 (0.67,1.67) 0.77 (0.40,1.47) 1.33 (0.79,2.22)
Non-Hodgkin’s (C83,85) n 12 22 18 6 12
HR (95% CI) 1.0 1.33 (0.64,2.76) 1.84 (0.87,3.86) 1.12 (0.39,3.16) 2.41 (1.08,5.41)
All others n 22 26 25 9 16
HR (95% CI) 1.0 0.94 (0.51,1.71) 1.27 (0.70,2.30) 0.97 (0.42,2.24) 1.84 (0.96,3.54)
Other skin (C44) n 1 2 9 5 4
HR (95% CI) 1.0 1.85 (0.16,21.53) 10.12 (1.24,82.95) 9.90 (1.03,95.57) 12.38 (1.36,112.71)

Hazard ratios (HRs) were adjusted for age, education, religion, mother tongue, and BMI; also shown is the 95% confidence interval of the HR obtained by fitting cox proportional hazards model

a

Name of the anatomic cancer site along with ICD code number

b

May include smokers of both bidis and cigarettes